Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014)
Bausch Health Companies (BHC) reported Non Operating Investment Income of $2.5 million for Q2 2014, down 35.9% on a YoY basis from $3.9 million in Q2 2013, and down 35.9% sequentially from $3.9 million in Q2 2013.
Bausch Health Companies (BHC) Non Operating Investment Income (2010 - 2014) Analysis & Trends
Bausch Health Companies (BHC) has 5 years of Non Operating Investment Income data on file, last reported at $2.5 million in Q2 2014.
- For the quarter ending Q2 2014, Non Operating Investment Income fell 35.9% year-over-year to $2.5 million; the trailing twelve-month figure through Jun 2015 stood at $2.5 million (down 60.94% YoY), and the FY2014 full-year result was $293.0 million, up 4951.72% from the prior year.
- Non Operating Investment Income eased to $2.5 million in Q2 2014, from $3.9 million in the prior quarter.
- In the past five years, Non Operating Investment Income ranged from a high of $21.2 million in Q2 2011 to a low of -$5.0 million in Q3 2010.
- A 5-year average of $2.1 million and a median of $76000.0 in 2012 frame the typical range for Non Operating Investment Income.
- Across the five-year window, Non Operating Investment Income sank 100.17% in 2012 and soared 11242.86% in 2013, its largest moves.
- Tracing BHC's Non Operating Investment Income over 5 years: stood at -$5.0 million in 2010, then soared by 99.78% to -$11000.0 in 2011, then surged by 790.91% to $76000.0 in 2012, then soared by 5031.58% to $3.9 million in 2013, then plunged by 35.9% to $2.5 million in 2014.
- Business Quant data shows BHC's Non Operating Investment Income at $2.5 million in Q2 2014, $3.9 million in Q2 2013, and $1.9 million in Q1 2013.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Investment Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.28 Bn | 87.42 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.97 Bn | 32.23 Bn | 1.97 Bn | - |
| 3 | Zoetis | 32.42 Bn | 30.48 Bn | 1.62 Bn | - |
| 4 | Takeda Pharmaceutical | 27.48 Bn | 23.42 Bn | 4.39 Bn | - |
| 5 | United Therapeutics | 22.89 Bn | 20.73 Bn | 648.10 Mn | - |
| 6 | RedHill Biopharma | 22.11 Bn | 22.11 Bn | - | - |
| 7 | Viatris | 20.44 Bn | 18.64 Bn | 1.16 Bn | - |
| 8 | Neurocrine Biosciences | 17.76 Bn | 16.44 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.62 Bn | 12.19 Bn | 785.00 Mn | - |
| 10 | Bausch Health Companies | 1.68 Bn | 367.46 Mn | 2.52 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2014 | 2.50 Mn |
| Jun 30, 2014 | 2.50 Mn |
| Jun 30, 2013 | 3.90 Mn |
| Jun 30, 2013 | 3.90 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Mar 31, 2013 | 1.86 Mn |
| Dec 31, 2012 | 76,000.00 |
| Dec 31, 2012 | 76,000.00 |
| Jun 30, 2012 | -35,000.00 |
| Jun 30, 2012 | -35,000.00 |
| Mar 31, 2012 | 2.06 Mn |
| Mar 31, 2012 | 2.06 Mn |
| Dec 31, 2011 | -11,000.00 |
| Dec 31, 2011 | -11,000.00 |
| Sep 30, 2011 | -140,000.00 |
| Sep 30, 2011 | -140,000.00 |
| Jun 30, 2011 | 21.16 Mn |
| Jun 30, 2011 | 21.16 Mn |
| Mar 31, 2011 | 1.77 Mn |
| Mar 31, 2011 | 1.77 Mn |